Effects of phenylbutazone on gene expression of cyclooxygenase-1 and -2 in the oral, glandular gastric, and bladder mucosae of healthy horses

American Journal of Veterinary Research

Volumn 73, Issue 1, 2012, Pages 98-104

  Nieto, Jorge E ^a   Aleman, Monica ^b   Anderson, Jonathan D ^b,c,d   Fiack, Ciara ^b   Snyder, Jack R ^a  

^a Department of Surgical and Radiological Sciences ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Egyesut Kiralysag   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PHENYLBUTAZONE; PLACEBO;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLADDER EXAMINATION; BLADDER MUCOSA; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFECT; ENDOSCOPY; EVALUATION; FEMALE; GENE EXPRESSION; MALE; MOUTH MUCOSA; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; STOMACH BIOPSY; STOMACH EXAMINATION; STOMACH MUCOSA; STOMACH ULCER; URINARY TRACT BIOPSY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYSTOSCOPY; FEMALE; GASTROSCOPY; GENE EXPRESSION REGULATION; HORSES; MALE; MOUTH; MUCOUS MEMBRANE; PHENYLBUTAZONE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH; URINARY BLADDER;

ANIMALIA; EQUIDAE; ZEA MAYS;

EID: 84855264068     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.1.98     Document Type: Article

References (39)

1. Blobaum AL, Marnett LJ. Structural and functional basis of cyclooxygenase inhibition. J Med Chem 2007;50:1425-1441.
2. Hersh EV, Lally ET, Moore PA. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray? Curr Med Res Opin 2005;21:1217-1226.
3. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145-182.
4. Goodrich LR, Nixon AJ. Medical treatment of osteoarthritis in the horse-a review. Vet J 2006;171:51-69.
5. Lees P, Michell AR. Phenylbutazone toxicity in ponies. Vet Rec 1979;105:150-151.
6. Snow DH, Bogan JA, Douglas TA, et al. Phenylbutazone toxicity in ponies. Vet Rec 1979;105:26-30.
7. Gunson DE, Soma LR. Renal papillary necrosis in horses after phenylbutazone and water deprivation. Vet Pathol 1983;20:603-610.
8. Reed SK, Messer NT, Tessman RK, et al. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. Am J Vet Res 2006;67:398-402.
9. Aleman M, Nieto JE, Higgins JK. Ulcerative cystitis associated with phenylbutazone administration in two horses. J Am Vet Med Assoc 2011;239:499-503.
10. Andrews F, Bernad W, Byars D, et al. Recommendations for the diagnosis and treatment of equine gastric ulcer syndrome (EGUS). The Equine Gastric Ulcer Council. Equine Vet Educ 1999;11:252-272.
11. Aleman M, Nieto EJ. Gene expression of proteolytic systems and growth regulators of skeletal muscle in horses with myopathy associated with pituitary pars intermedia dysfunction Am J Vet Res 2010;71:664-670.
12. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
13. Hilton H, Nieto JE, Moore PF, et al. Expression of cyclooxygenase genes in the jejunum of horses during low-flow ischemia and reperfusion. Am J Vet Res 2011;72:681-686.
14. Tellmann G. The E-method: a highly accurate technique for gene-expression analysis. Nat Methods 2006;3:i-ii.
15. Reef VB. Adult abdominal ultrasonography. In: Equine diagnostic ultrasound. Philadelphia: WB Saunders Co, 1998;282-284.
16. Cannon JH. Ultrasound of the equine stomach, in Proceedings. 41st Annu Meet Am Assoc Equine Pract 1995;38-39.
17. Hoffmann KL, Wood AK, McCarthy PH. Sonographic-anatomic correlation and imaging protocol for the kidneys of horses. Am J Vet Res 1995;56:1403-1412.
18. Rouzer CA, Marnett LJ. Cyclooxygenases: structural and functional insights. J Lipid Res 2009;50(suppl):S29-S34.
19. Murray MJ. Pathophysiology of peptic disorders in foals and horses: a review. Equine Vet J Suppl 1999;(29):14-18.
20. Collins LG, Tyler DE. Phenylbutazone toxicosis in the horse: a clinical study. J Am Vet Med Assoc 1984;184:699-703.
21. Monreal L, Sabate D, Segura D, et al. Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses. Res Vet Sci 2004;76:145-149.
22. Geor RJ, Petrie L, Papich MG, et al. The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone. Can J Vet Res 1989;53:231-238.
23. Lipsky PE, Brooks P, Crofford LJ, et al. Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease. Arch Intern Med 2000;160:913-920.
24. Tomlinson JE, Wilder BO, Young KM, et al. Effects of flunixin meglumine or etodolac treatment on mucosal recovery of equine jejunum after ischemia. Am J Vet Res 2004;65:761-769.
25. Wooten JG, Blikslager AT, Ryan KA, et al. Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs. Am J Vet Res 2008;69:457-464.
26. Davies NM, Sharkey KA, Asfaha S, et al. Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 1997;11:1101-1108.
27. MacAllister CG, Morgan SJ, Borne AT, et al. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc 1993;202:71-77.
28. Ramirez S, Seahorn TL, Williams J. Renal medullary rim sign in 2 adult quarter horses. Can Vet J 1998;39:647-649.
29. Black HE. Renal toxicity of non-steroidal anti-inflammatory drugs. Toxicol Pathol 1986;14:83-90.
30. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984;310:563-572.
31. American Quarter Horse Association. Shows rules and regulations. In: Official handbook of rules and regulations. Amarillo, Tex: American Quarter Horse Association, 2008.
32. Fédération Equestre Internationale. Prohibited substances list. In: Veterinary rules. 12th ed. Lausanne, Switzerland: Fédération Equestre Internationale, 2010.
33. McConnico RS, Morgan TW, Williams CC, et al. Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses. Am J Vet Res 2008;69:1496-1505.
34. Snow DH, Douglas TA, Thompson H, et al. Phenylbutazone toxicosis in equidae: a biochemical and pathophysiological study. Am J Vet Res 1981;42:1754-1759.
35. Doucet MY, Bertone AL, Hendrickson D, et al. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis. J Am Vet Med Assoc 2008;232:91-97.
36. US FDA Center for Veterinary Medicine. Freedom of information summary. EQUIOXX oral paste-0.82% firocoxib (w/w). NADA 141-253. Rockville, Md: US FDA, 2005.
37. Campbell NB, Blikslager AT. The role of cyclooxygenase inhibitors in repair of ischaemic-injured jejunal mucosa in the horse. Equine Vet J Suppl 2000;(32):59-64.
38. Cook VL, Meyer CT, Campbell NB, et al. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum. Am J Vet Res 2009;70:992-1000.
39. Roberts PJ, Morgan K, Miller R, et al. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 2001;48:468-472.